Juan Manuel Fernández

ORCID: 0000-0001-9567-9025
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Bone Tissue Engineering Materials
  • biodegradable polymer synthesis and properties
  • HIV Research and Treatment
  • HIV/AIDS drug development and treatment
  • Bone Metabolism and Diseases
  • Bone health and osteoporosis research
  • Animal Disease Management and Epidemiology
  • Genetic factors in colorectal cancer
  • Orthopaedic implants and arthroplasty
  • Advanced Glycation End Products research
  • Colorectal Cancer Screening and Detection
  • Bone health and treatments
  • T-cell and Retrovirus Studies
  • Polyoxometalates: Synthesis and Applications
  • BRCA gene mutations in cancer
  • HIV/AIDS Research and Interventions
  • Metabolism, Diabetes, and Cancer
  • Knee injuries and reconstruction techniques
  • HIV-related health complications and treatments
  • Silicon Nanostructures and Photoluminescence
  • Osteoarthritis Treatment and Mechanisms
  • Semiconductor materials and devices
  • Bone and Joint Diseases
  • Vector-Borne Animal Diseases
  • Graphene and Nanomaterials Applications

Universidad Nacional de La Plata
2013-2024

Hospital Posadas
2024

Fundación Ciencias Exactas y Naturales
2023

Consejo Nacional de Investigaciones Científicas y Técnicas
2023

University of Buenos Aires
2023

Hospital de Poniente
2017-2023

Hospital Universitario de Gran Canaria Doctor Negrín
2018-2022

Laboratoire des Matériaux Avancés
2020

Instituto de Investigación Biosanitaria de Granada
2007-2015

Instituto de Investigaciones Fisicoquímicas Teóricas y Aplicadas
2010-2014

BackgroundExposure to xenoestrogens during pregnancy may disturb the development and function of male sexual organs.ObjectiveIn this study we aimed determine whether combined effect environmental estrogens measured as total effective xenoestrogen burden (TEXB) is a risk factor for urogenital malformations.MethodsIn case–control study, nested in mother–child cohort (n = 702) established at Granada University Hospital, compared 50 newborns with diagnosis cryptorchidism and/or hypospadias 114...

10.1289/ehp.9351 article EN public-domain Environmental Health Perspectives 2007-06-01

Hydroxyapatite (HAP)-containing poly-ε-caprolactone (PCL)–polydiisopropyl fumarate (PDIPF) composite (Blend) was developed as an alternative for bone tissue engineering. The physicochemical, mechanical and biocompatibility properties of these composites were evaluated using two osteoblast-like cell lines (UMR106 MC3T3E1) compared with the blend without HAP PCL/HAP films. increment in elastic modulus decrease elongation-at-break Blend–HAP suggest that scaffolds have improved significantly....

10.1002/term.394 article EN Journal of Tissue Engineering and Regenerative Medicine 2011-02-10

A broader extent of amino acid substitutions in the integrase HIV-2 compared with HIV-1 might enable greater cross-resistance between raltegravir and dolutegravir infection. Few studies have examined virological response to patients that failed raltegravir.All recorded Spanish cohort were examined. The coding region was sequenced viraemic patients. Changes associated resistance recorded.From 319 HIV-2-infected cohort, 53 sequences from 30 individuals obtained (20 naive 10 experienced). Only...

10.1093/jac/dkx090 article EN Journal of Antimicrobial Chemotherapy 2017-03-02

In contrast with HIV-1, information about drug resistance in HIV-2 is scarce and mainly derived from small series of patients failing antiretroviral therapy. The spectrum changes the reverse transcriptase (RT), protease (PR) integrase (INT) genes was examined individuals enrolled Spanish register. From a total 236 HIV-2-infected registered Spain 1989 to June 2010, 53 PR, 44 RT 8 INT sequences were obtained. Low plasma viraemia precluded collection this most remaining cases. No major...

10.1093/jac/dkr164 article EN Journal of Antimicrobial Chemotherapy 2011-05-10

The present study was designed to investigate the possible cytotoxicity and biocompatibility of scaffolds based on previously characterized polymeric materials including poly--caprolactone (PCL) or polydiisopropyl fumarate (blended their own), with without hydroxyapatite (HAP).Water contact angle also evaluated determine hydrophylicity each scaffold.Degradation different after a 10-week incubation in Dulbecco's modified eagle medium (DMEM) supplemented 5% (v/v) fetal bovine serum (FBS).Bone...

10.1166/jbt.2014.1158 article EN Journal of Biomaterials and Tissue Engineering 2014-03-01

Abstract There is considerable interest in the design of polymeric biomaterials that can be used for repair bone defects. In this study, we ultrasound to prepare a compatibilized blend poly(ε-caprolactone) (PCL) and poly(diisopropyl fumarate) (PDIPF). The formation post-sonication inter-polymer coupling products was verified by SEC analysis with azo-labeled PDIPF. We also analyzed physicochemical mechanical properties blend. When compared PCL alone, PCL/PDIPF showed no difference its...

10.1163/092050609x12517190417632 article EN Journal of Biomaterials Science Polymer Edition 2010-01-01

HIV-2 is a neglected virus despite estimates of 1-2 million people being infected worldwide. The naturally resistant to some antiretrovirals used treat HIV-1 and therapeutic options are limited for patients with HIV-2.In this retrospective observational study, we analysed all HIV-2-infected individuals treated integrase strand transfer inhibitors (INSTIs) recorded in the Spanish cohort. Demographics, treatment modalities, laboratory values, quantitative RNA CD4 counts as well drug resistance...

10.1093/jac/dkz007 article EN Journal of Antimicrobial Chemotherapy 2019-01-31

Abstract Background Autosomal dominant polycystic kidney disease (ADPKD) causes about 10% of cases end stage renal disease. Disease progression rate is heterogeneous. Tolvaptan presently the only specific therapeutic option to slow function decline in adults at risk rapidly progressing ADPKD with chronic (CKD) stages 1–4. Thus, a reliable evaluation patients needed. Methods We evaluated agreement between measured (mGFR) and estimated glomerular filtration (eGFR) by 61 formulas based on...

10.1007/s40620-022-01286-0 article EN cc-by Journal of Nephrology 2022-03-31

Current efforts in bone tissue engineering have as one focus the search for a scaffold material that supports osteoblast proliferation, matrix mineralization, and, ultimately, formation.Electrospraying of polymer solutions has enabled porous materials to meet current challenges replacement therapies.Porous scaffolds poly(-caprolactone)/poly(diisopropyl fumarate) compatibilized blend were obtained by electrospraying technique order create better osteophilic environment growth and...

10.1166/jbt.2011.1002 article EN Journal of Biomaterials and Tissue Engineering 2011-06-01
Lourdes Roc Carmen de Mendoza Miriam Fernández‐Alonso Gabriel Reina Vincent Soriano and 95 more Conrado Fernández‐Rodríguez Mar Vera Jorge del Romero Goizane Marcaida María Dolores Ocete E. Caballero Israel Molina A. Aguilera José Javier Rodríguez Daniel Navarro Cecilia Rivero M.D. Vilariño Rafael Benito Sonia Algarate Joan Gil Raúl Ortíz de Lejarazu S Rojo José María Eirós Bouza A. San Miguel Christian Manzardo José M. Miró J.H. de Gea-García I. Paz Eva Poveda Enrique J. Calderón Domingo Escudero M.M. Trigo José Carlos Diz Marta García‐Campello Manuel Rodríguez‐Iglesias A. Hernández-Betancor Anna Martin José Manuel Ramos Adelina Gimeno Félix Gutiérrez Juan Carlos Rodrı́guez V. Sánchez Sánchez César Gómez-Hernando Gustavo Cilla E. Pérez-Trallero José López‐Aldeguer Luis Fernández-Pereira Jordí Niubó María José Hernández A. López-Lirola Juan Luís Gómez-Sirvent Lluís Force Celia Cifuentes Salvador Pérez Luís Morano Carmen Raya Alejandro González‐Praetorius J.L. Pérez María Luz Pintos Peñaranda Silvia Hernáez-Crespo José Miguel Montejo Lourdes Roc Ana Martínez-Sapiña Isabel Viciana Teresa Cabezas Alejandro Lozano Juan Manuel Fernández Isabel García-Bermejo G. Gaspar R. García Miguel Górgolas Carlos del Pozo Vegas José Blas Pilar Miralles Miguel González Valeiro Teresa Aldámiz N Margall C. Guardià Elaine Pico Inmaculada Ortiz Polo A. Aguinaga Carmen Ezpeleta Silvia Sauleda María Pirón Ruperto González‐Pérez Luisa Barea Antonio Jiménez Lidia Rodríguez Blanco A. Suárez Iciar Rodríguez-Avial Alfredo Pérez‐Rivilla Patricia Parra M. Fernández Miriam Fernández‐Alonso Gabriel Reina Ana Treviño Silvia Requena Laura Benítez‐Gutiérrez Valentín Cuervas‐Mons Carmen de Mendoza

Two kidney transplant recipients from a single donor became infected with HTLV-1 (human T-lymphotropic virus type 1) in Spain. One developed myelopathy 8 months following surgery despite early prescription of antiretroviral therapy. The allograft was removed the second recipient at month due to rejection and immunosuppressors discontinued. To date, 3 years later, this patient remains but asymptomatic. infection recognized retrospectively donor, native Spaniard who had sex partners endemic...

10.1177/2049936119868028 article EN cc-by-nc Therapeutic Advances in Infectious Disease 2019-01-01
Carmen de Mendoza Ariadna Rando‐Segura Elisenda Miró María José Pena Iciar Rodríguez-Avial and 95 more Diego Ortega Alejandro González‐Praetorius Gabriel Reina Ilduara Pintos María José Pozuelo Vincent Soriano Enrique J. Calderón Manuel Rodríguez‐Iglesias Natalia Montiel Toby C. Trujillo Isabel Viciana Teresa Cabezas A. Lozano Elisa Fernández-Fuertes Juan Manuel Fernández Féderico García Rafael Benito Sonia Algarate María Ducons Lourdes Roc Celia Cifuentes Victoria Fernández‐Baca José Vicente Fernández-Montero MD. Maciá A. Hernández-Betancor A. M. Martín María José Mellado Marta Hernández A. López-Lirola Juan Luís Gómez-Sirvent Rodolfo Copado M.E. Cano S Rojo José María Eirós Bouza Manuel Rodríguez César Gómez-Hernando Alejandro González‐Praetorius Ariadna Rando‐Segura Lluís Force Elisenda Miró A. Cebollero J.F. Delgado G. Rodríguez-Laiz Luis Fernández-Pereira Antonio Aguilera S. Pereira Juan González‐García Matilde Trigo J. Diz Marta García‐Campello S. Cortizo Salvador Pérez Luís Morano Gabriel Reina M. Arazamendi Y. Salicio Estíbaliz Ugalde M C Nieto Paloma Liendo Ane Josune Goikoetxea María Dolores Ocete José Manuel Ramos Isabel Escribano Silvia Sauleda María Pirón Ruperto González‐Pérez Alberto Richart Luisa Barea Antonio Jiménez Lidia Rodríguez Blanco Lourdes Navarro Oskar Ayerdi Begoña Baza Carmen Rodríguez Jorge del Romero Alicia Galar Teresa Aldámiz Miguel González Valeiro Lester J. Pérez Iciar Rodríguez-Avial Luz Martín‐Carbonero Mario Fernández‐Ruiz Patricia Parra Natalia Redondo Tamara Ruiz‐Merlo María José Pozuelo Pablo Barreiro Ana Treviño Octavio Corral Vincent Soriano Ilduara Pintos Víctor Moreno‐Torres P. Carrizo A. Huertas J.A. Vargas-Núñez

10.1016/j.jcv.2023.105578 article EN Journal of Clinical Virology 2023-08-29

We previously showed that a 3-week oral metformin (MET) treatment enhances the osteogenic potential of bone marrow stromal cells (BMSCs) and improves several histomorphometric parameters in Wistar rats with metabolic syndrome (MetS). However, skeletal effects extended periods MET need to be completely elucidated. Hence, this study, impact prolonged (3-month) was investigated on architecture, biomechanics variables, BMSCs or without MetS.

10.1055/a-2324-8661 article EN Experimental and Clinical Endocrinology & Diabetes 2024-05-13

Abstract The objective of this study was to test a regenerative medicine strategy for the regeneration articular cartilage. This approach combines microfracture subchondral bone with implant at site cartilage defect supporting biomaterial in form microspheres aimed creating an adequate biomechanical environment differentiation mesenchymal stem cells that migrate from marrow. possible inflammatory response these biomaterials previously studied by means culture RAW264.7 macrophages. were...

10.1002/jbm.b.34490 article EN Journal of Biomedical Materials Research Part B Applied Biomaterials 2019-09-14

An initial Phase III clinical trial has evaluated the efficacy and safety of biosimilar recombinant human growth hormone (rhGH; Omnitrope(®), Sandoz) in Spanish children with deficiency (GHD). At end study, those patients still growing were offered to remain on treatment (as usual practice), continued be monitored. The aim this study was determine adult height achieved by who participated trial, evaluate long-term rhGH treatment.This a multicenter, observational, retrospective follow-up (70...

10.1007/s12325-015-0181-9 article EN cc-by-nc Advances in Therapy 2015-02-01
Carmen de Mendoza María Pirón Rocío González Ana Belén Jiménez Estrella Caballero and 95 more Lourdes Roc Rafael Benito José Manuel Ramos Vincent Soriano Carmen Rodríguez Mar Vera Jorge del Romero Goizane Marcaida María Dolores Ocete E. Caballero Israel Molina Antonio Aguilera José Javier Rodríguez Daniel Navarro Cecilia Rivero M.D. Vilariño Rafael Benito Sonia Algarate Joan Gil Raúl Ortíz de Lejarazu S Rojo José María Eirós Bouza A. San Miguel Christian Manzardo José M. Miró J.J. Rubio García Isabel Pavón de Paz Eva Poveda Enrique J. Calderón Domingo Escudero M.M. Trigo José Carlos Diz Marta García‐Campello Manuel Rodríguez‐Iglesias Araceli Hernández-Betancor Anna Martin José Manuel Ramos Adelina Gimeno Félix Gutiérrez Juan Carlos Rodrı́guez Víctor Sánchez César Gómez-Hernando Gustavo Cilla Emilio Pérez‐Trallero José López‐Aldeguer L. Fernandez-Pereira Jordí Niubó María José Hernández A. López-Lirola Juan Luís Gómez-Sirvent Lluís Force Celia Cifuentes Salvador Pérez Luís Morano Carmen Raya Alejandro González‐Praetorius J L Pérez María Luz Pintos Peñaranda Silvia Hernáez-Crespo J M Montejo Lourdes Roc Ana Martínez-Sapiña Isabel Viciana Teresa Cabezas A. Lozano Juan Manuel Fernández Isabel García-Bermejo G. Gaspar Roberto J. García Miguel Górgolas Carmen Asensio Vegas Juan Luís Blas Pedro Moruno Miralles Miguel González Valeiro Teresa Aldámiz N Margall C. Guardià Elaine Pico Inmaculada Ortiz Polo A. Aguinaga Carmen Ezpeleta Silvia Sauleda María Pirón P. Torres Ruperto González‐Pérez Antonio Jiménez Laura Solán A Suárez Iciar Rodríguez-Avial Alfredo Pérez‐Rivilla Patricia Parra M Fernández Miriam Fernández‐Alonso A. Trevino Silvia Requena

Although only 8%-10% of persons infected with human T-cell leukemia virus type 1 (HTLV-1) may develop virus-associated diseases lifelong, misdiagnosis asymptomatic carriers frequently leads to late diagnoses.A nationwide HTLV-1 register was created in Spain 1989. A total 351 had been reported by the end 2017. We examined all new diagnoses during last decade and compared their clinical presentation.A 247 individuals infection since year 2008. The incidence has remained stable 20-25 yearly....

10.1093/ofid/ofz036 article EN cc-by-nc-nd Open Forum Infectious Diseases 2019-01-16
Coming Soon ...